In the context of the cancer treatment approaches, the computational findings proposed that EGFR, MAPK3, CCND1, FGF2, CHEK1, VEGFA, RELA, and ERBB3 have potential efficacy biomarkers for BC. The gene discussed is FGF2; the disease is cancer.